Pros and cons of fatty acids in bone biology

James, 2008, WHO recognition of the global obesity epidemic, Int J Obes (Lond), 32, S120, 10.1038/ijo.2008.247 Felson, 1993, Effects of weight and body mass index on bone mineral density in men and women: the Framingham study, J Bone Miner Res, 8, 567, 10.1002/jbmr.5650080507 Reid, 2002, Relationships among body mass, its components, and bone, Bone, 31, 547, 10.1016/S8756-3282(02)00864-5 Reid, 1992, Determinants of total body and regional bone mineral density in normal postmenopausal women–a key role for fat mass, J Clin Endocrinol Metab, 75, 45 Reid, 1992, Fat mass is an important determinant of whole body bone density in premenopausal women but not in men, J Clin Endocrinol Metab, 75, 779 Adachi, 2010, Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women, Mayo Clin Proc, 85, 806, 10.4065/mcp.2010.0082 Rizzoli, 2011, Adverse reactions and drug–drug interactions in the management of women with postmenopausal osteoporosis, Calcif Tissue Int, 89, 91, 10.1007/s00223-011-9499-8 Gimble, 1996, The function of adipocytes in the bone marrow stroma: an update, Bone, 19, 421, 10.1016/S8756-3282(96)00258-X Starcke, 2006, Is there an estrogenic component in the metabolic syndrome?, Genes Nutr, 1, 177, 10.1007/BF02829967 Blum, 2003, Leptin, body composition and bone mineral density in premenopausal women, Calcif Tissue Int, 73, 27, 10.1007/s00223-002-1019-4 De Laet, 2005, Body mass index as a predictor of fracture risk: a meta-analysis, Osteoporos Int, 16, 1330, 10.1007/s00198-005-1863-y Hsu, 2006, Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women, Am J Clin Nutr, 83, 146, 10.1093/ajcn/83.1.146 Zhao, 2007, Relationship of obesity with osteoporosis, J Clin Endocrinol Metab, 92, 1640, 10.1210/jc.2006-0572 Laneuville, 1995, Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid, J Biol Chem, 270, 19330, 10.1074/jbc.270.33.19330 Raisz, 1989, Effects of prostaglandin E3 and eicosapentaenoic acid on rat bone in organ culture, Prostaglandins, 37, 615, 10.1016/0090-6980(89)90076-2 Corwin, 2003, Effects of dietary fats on bone health in advanced age, Prostaglandins Leukot Essent Fatty Acids, 68, 379, 10.1016/S0952-3278(03)00062-0 Calder, 2006, N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases, Am J Clin Nutr, 83, 1505S, 10.1093/ajcn/83.6.1505S Ono, 2005, Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor, J Bone Miner Res, 20, 23, 10.1359/jbmr.2005.20.1.23 Tsutsumi, 2009, PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis, J Bone Miner Res, 24, 1753, 10.1359/jbmr.090412 De Benedetti, 2006, Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system, Arthritis Rheum, 54, 3551, 10.1002/art.22175 Wauquier, 2009, Oxidative stress in bone remodelling and disease, Trends Mol Med, 15, 468, 10.1016/j.molmed.2009.08.004 Briscoe, 2003, The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids, J Biol Chem, 278, 11303, 10.1074/jbc.M211495200 Brown, 2003, The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids, J Biol Chem, 278, 11312, 10.1074/jbc.M211609200 Diascro, 1998, High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells, J Bone Miner Res, 13, 96, 10.1359/jbmr.1998.13.1.96 Himes, 2010, Tlr2 is critical for diet-induced metabolic syndrome in a murine model, FASEB J, 24, 731, 10.1096/fj.09-141929 Hwang, 2001, Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways, FASEB J, 15, 2556, 10.1096/fj.01-0432com Maurin, 2005, Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids, Calcif Tissue Int, 76, 385, 10.1007/s00223-004-0108-y Legrand, 2007, Les acides gras: structures, fonctions, apports nutritionnels conseillés, Cah Nutr Diét, 42, 10.1016/S0007-9960(07)91234-1 Albertazzi, 2002, Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?, Maturitas, 42, 13, 10.1016/S0378-5122(02)00022-1 Calder, 2006, Polyunsaturated fatty acids and inflammation, Prostaglandins Leukot Essent Fatty Acids, 75, 197, 10.1016/j.plefa.2006.05.012 Fernandes, 2003, Protective role of n-3 lipids and soy protein in osteoporosis, Prostaglandins Leukot Essent Fatty Acids, 68, 361, 10.1016/S0952-3278(03)00060-7 Kim, 2011, Implications of dietary alpha-linolenic acid in bone health, Nutrition (Burbank, Los Angeles County, Calif), 27, 1101, 10.1016/j.nut.2011.05.012 Kruger, 2010, Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone, Prog Lipid Res, 49, 438, 10.1016/j.plipres.2010.06.002 Kruger, 1997, Calcium metabolism, osteoporosis and essential fatty acids: a review, Prog Lipid Res, 36, 131, 10.1016/S0163-7827(97)00007-6 Poulsen, 2007, Long-chain polyunsaturated fatty acids and the regulation of bone metabolism, Exp Biol Med (Maywood), 232, 1275, 10.3181/0704-MR-100 Salari, 2008, A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis, Med Sci Monit, 14, RA37 Seifert, 1997, Role of dietary lipid and antioxidants in bone metabolism, Nutr Res (New York, NY), 17, 1209, 10.1016/S0271-5317(97)00090-0 Watkins, 2003, Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism, Prostaglandins Leukot Essent Fatty Acids, 68, 387, 10.1016/S0952-3278(03)00063-2 Watkins, 2001, Omega-3 polyunsaturated fatty acids and skeletal health, Exp Biol Med (Maywood), 226, 485, 10.1177/153537020122600601 Watkins, 2001, Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology, J Am Coll Nutr, 24, 410S, 10.1080/07315724.2001.10719177 Watkins, 2001, Bioactive fatty acids: role in bone biology and bone cell function, Prog Lipid Res, 40, 125, 10.1016/S0163-7827(00)00016-3 Borland, 1931, Effects of a fat-free diet on the structure of the kidney in rats, Arch Pathol, 11, 687 Alfin Slater, 1958, Changes in tissue lipids and tissue histology resulting from essential fatty acid deficiency in rats, Am J Clin Nutr, 6, 613, 10.1093/ajcn/6.6.613 Biran, 1964, Studies on essential fatty acid deficiency. Effect of the deficiency on the lipids in various rat tissues and the influence of dietary supplementation with essential fatty acids on deficient rats, Biochem J, 93, 492, 10.1042/bj0930492 Corwin, 2006, Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III, J Nutr, 136, 159, 10.1093/jn/136.1.159 Jeong, 2010, Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea, Calcif Tissue Int, 87, 507, 10.1007/s00223-010-9427-3 Puel, 2004, Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat, Br J Nutr, 92, 119, 10.1079/BJN20041181 Rezq, 2010, Effect of some dietary oils and fats on serum lipid profile, calcium absorption and bone mineralization in mice, Pak J Nutr, 9, 643, 10.3923/pjn.2010.643.650 Saleh, 2011, Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats, BMC Complement Altern Med, 11, 10, 10.1186/1472-6882-11-10 Martinez-Ramirez, 2007, Dietary fat intake and the risk of osteoporotic fractures in the elderly, Eur J Clin Nutr, 61, 1114, 10.1038/sj.ejcn.1602624 Orchard, 2010, Fatty acid consumption and risk of fracture in the Women’s Health Initiative, Am J Clin Nutr, 92, 1452, 10.3945/ajcn.2010.29955 Macdonald, 2004, Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids, Am J Clin Nutr, 79, 155, 10.1093/ajcn/79.1.155 Sun, 2003, Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice, J Bone Miner Res, 18, 1206, 10.1359/jbmr.2003.18.7.1206 Zeitlin, 2003, Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice, J Cell Biochem, 90, 347, 10.1002/jcb.10620 Cohen, 2005, Flaxseed oil and bone development in growing male and female mice, J Toxicol Environ Health A, 68, 1861, 10.1080/15287390500226516 Bhattacharya, 2007, Effect of fish oil on bone mineral density in aging C57BL/6 female mice, J Nutr Biochem, 18, 372, 10.1016/j.jnutbio.2006.07.002 Coetzer, 1994, Calcium transport by isolated brush border and basolateral membrane vesicles: role of essential fatty acid supplementation, Prostaglandins Leukot Essent Fatty Acids, 50, 257, 10.1016/0952-3278(94)90164-3 Sakaguchi, 1994, Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats, Prostaglandins Leukot Essent Fatty Acids, 50, 81, 10.1016/0952-3278(94)90151-1 Sakaguchi, 1994, Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats, Prostaglandins Leukot Essent Fatty Acids, 50, 81, 10.1016/0952-3278(94)90151-1 Green, 2004, The effect of dietary n-3 long-chain polyunsaturated fatty acids on femur mineral density and biomarkers of bone metabolism in healthy, diabetic and dietary-restricted growing rats, Prostaglandins Leukot Essent Fatty Acids, 71, 121, 10.1016/j.plefa.2004.03.001 Kruger, 2005, Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability?, Prostaglandins Leukot Essent Fatty Acids, 73, 327, 10.1016/j.plefa.2005.08.001 Lukas, 2011, Consumption of different sources of omega-3 polyunsaturated fatty acids by growing female rats affects long bone mass and microarchitecture, Bone, 49, 455, 10.1016/j.bone.2011.05.029 Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, Br J Nutr, 83, 629, 10.1017/S0007114500000805 Farina, 2011, Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study, Am J Clin Nutr, 93, 1142, 10.3945/ajcn.110.005926 van Papendorp, 1995, Biochemical profile of osteoporotic patients on essential fatty acid supplementation, Nutr Res (New York, NY), 15, 325, 10.1016/0271-5317(95)00002-X Zwart, 2010, Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts, J Bone Miner Res, 25, 1049 Banu, 2010, Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice, J Bone Miner Metab, 28, 617, 10.1007/s00774-010-0175-2 Lau, 2009, Femur EPA and DHA are correlated with femur biomechanical strength in young fat-1 mice, J Nutr Biochem, 20, 453, 10.1016/j.jnutbio.2008.05.004 Wauquier, 2012, Borage and fish oils lifelong supplementation decreases inflammation and improves bone health in a murine model of senile osteoporosis, Bone, 50, 553, 10.1016/j.bone.2011.05.030 Claassen, 1995, Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content, Bone, 16, 385S, 10.1016/S8756-3282(95)80481-1 Watkins, 2006, Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats, J Nutr Biochem, 17, 282, 10.1016/j.jnutbio.2005.05.012 Mollard, 2005, Low levels of dietary arachidonic and docosahexaenoic acids improve bone mass in neonatal piglets, but higher levels provide no benefit, J Nutr, 135, 505, 10.1093/jn/135.3.505 Weiler, 2002, Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets, J Nutr, 132, 2667, 10.1093/jn/132.9.2667 Hogstrom, 2007, N-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study, Am J Clin Nutr, 85, 803, 10.1093/ajcn/85.3.803 Poulsen, 2006, Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats, Prostaglandins Leukot Essent Fatty Acids, 75, 419, 10.1016/j.plefa.2006.08.003 Schlemmer, 1999, Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat, Prostaglandins Leukot Essent Fatty Acids, 61, 381, 10.1054/plef.1999.0116 Shen, 2006, Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats, Br J Nutr, 95, 462, 10.1079/BJN20051664 Yamada, 1995, Effect of eicosapentaenoic acid and docosahexaenoic acid on diabetic osteopenia, Diabetes Res Clin Pract, 30, 37, 10.1016/0168-8227(95)01139-0 Blanaru, 2004, Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula, Am J Clin Nutr, 79, 139, 10.1093/ajcn/79.1.139 Lucia, 2003, Dietary arachidonic acid suppresses bone turnover in contrast to low dosage exogenous prostaglandin E2 that elevates bone formation in the piglet, Prostaglandins Leukot Essent Fatty Acids, 68, 407, 10.1016/S0952-3278(03)00065-6 Watkins, 2000, Conjugated linoleic acid and bone biology, J Am Coll Nutr, 19, 478S, 10.1080/07315724.2000.10718951 Griel, 2007, An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans, Nutr J, 6, 2, 10.1186/1475-2891-6-2 Halade, 2011, Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice, J Nutr Biochem, 22, 459, 10.1016/j.jnutbio.2010.03.015 Li, 1999, Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids, J Bone Miner Res, 14, 1153, 10.1359/jbmr.1999.14.7.1153 Rahman, 2007, Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice, J Nutr Biochem, 18, 467, 10.1016/j.jnutbio.2006.08.002 Rahman, 2011, T10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity, J Cell Physiol, 226, 2406, 10.1002/jcp.22578 Duque, 2008, Bone and fat connection in aging bone, Curr Opin Rheumatol, 20, 429, 10.1097/BOR.0b013e3283025e9c Gimble, 2006, Playing with bone and fat, J Cell Biochem, 98, 251, 10.1002/jcb.20777 Reid, 2008, Relationships between fat and bone, Osteoporos Int, 19, 595, 10.1007/s00198-007-0492-z Rosen, 2009, Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis, Am J Med, 122, 409, 10.1016/j.amjmed.2008.11.027 Rosen, 2006, Mechanisms of disease: is osteoporosis the obesity of bone?, Nat Clin Pract, 2, 35, 10.1038/ncprheum0070 Bredella, 2014, Positive effects of brown adipose tissue on femoral bone structure, Bone, 58, 55, 10.1016/j.bone.2013.10.007 Rahman, 2013, Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton, Endocrinology, 154, 2687, 10.1210/en.2012-2162 Ducy, 2000, Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass, Cell, 100, 197, 10.1016/S0092-8674(00)81558-5 Takeda, 2002, Leptin regulates bone formation via the sympathetic nervous system, Cell, 111, 305, 10.1016/S0092-8674(02)01049-8 Elefteriou, 2005, Leptin regulation of bone resorption by the sympathetic nervous system and CART, Nature, 434, 514, 10.1038/nature03398 Cornish, 2002, Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo, J Endocrinol, 175, 405, 10.1677/joe.0.1750405 Martin, 2005, Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats, Endocrinology, 146, 3652, 10.1210/en.2004-1509 Gordeladze, 2002, Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling, J Cell Biochem, 85, 825, 10.1002/jcb.10156 Lamghari, 2006, Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts, J Cell Biochem, 98, 1123, 10.1002/jcb.20853 Reseland, 2001, Reduction of leptin gene expression by dietary polyunsaturated fatty acids, J Lipid Res, 42, 743, 10.1016/S0022-2275(20)31636-9 Ukropec, 2003, The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression, Lipids, 38, 1023, 10.1007/s11745-006-1156-z Gudbrandsen, 2009, Trans-10, cis-12-conjugated linoleic acid reduces the hepatic triacylglycerol content and the leptin mRNA level in adipose tissue in obese Zucker fa/fa rats, Br J Nutr, 102, 803, 10.1017/S0007114509297200 Noto, 2007, Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats, Metab, Clin Exp, 56, 1601, 10.1016/j.metabol.2007.06.025 Perez-Matute, 2007, Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes, Mol Cell Endocrinol, 268, 50, 10.1016/j.mce.2007.01.013 Perez-Matute, 2007, Linoleic acid decreases leptin and adiponectin secretion from primary rat adipocytes in the presence of insulin, Lipids, 42, 913, 10.1007/s11745-007-3092-y Martin, 2007, Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway, Endocrinology, 148, 3419, 10.1210/en.2006-1541 Guidobono, 2006, Different skeletal regional response to continuous brain infusion of leptin in the rat, Peptides, 27, 1426, 10.1016/j.peptides.2005.10.014 Hamrick, 2004, Leptin deficiency produces contrasting phenotypes in bones of the limb and spine, Bone, 34, 376, 10.1016/j.bone.2003.11.020 Berner, 2004, Adiponectin and its receptors are expressed in bone-forming cells, Bone, 35, 842, 10.1016/j.bone.2004.06.008 Luo, 2005, Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway, Exp Cell Res, 309, 99, 10.1016/j.yexcr.2005.05.021 Kanazawa, 2007, Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells, BMC Cell Biol, 8, 51, 10.1186/1471-2121-8-51 Yamaguchi, 2008, Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling, FEBS Lett, 582, 451, 10.1016/j.febslet.2007.12.037 Shinoda, 2006, Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways, J Cell Biochem, 99, 196, 10.1002/jcb.20890 Lenchik, 2003, Adiponectin as a novel determinant of bone mineral density and visceral fat, Bone, 33, 646, 10.1016/S8756-3282(03)00237-0 Peng, 2008, Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men, Clin Chim Acta, 387, 31, 10.1016/j.cca.2007.08.012 Napoli, 2010, Adiponectin and bone mass density: the InCHIANTI study, Bone, 47, 1001, 10.1016/j.bone.2010.08.010 Ealey, 2008, Adiponectin is a negative regulator of bone mineral and bone strength in growing mice, Exp Biol Med (Maywood), 233, 1546, 10.3181/0806-RM-192 Luo, 2006, Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway, J Bone Miner Res, 21, 1648, 10.1359/jbmr.060707 Perez de Heredia, 2009, Adiponectin is associated with serum and adipose tissue fatty acid composition in rats, J Endocrinol Invest, 32, 659, 10.1007/BF03345737 Saravanan, 2005, Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue, Eur J Endocrinol, 153, 159, 10.1530/eje.1.01946 Todoric, 2006, Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids, Diabetologia, 49, 2109, 10.1007/s00125-006-0300-x Oster, 2010, Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes, Appl Physiol Nutr Metab, 35, 783, 10.1139/H10-076 Tishinsky, 2010, Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes, Obesity (Silver Spring, Md), 19, 262, 10.1038/oby.2010.186 Poirier, 2006, Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue, Diabetes, 55, 1634, 10.2337/db06-0036 Ahn, 2006, Isomer-specific effect of conjugated linoleic acid on inflammatory adipokines associated with fat accumulation in 3T3-L1 adipocytes, J Med Food, 9, 307, 10.1089/jmf.2006.9.307 Khosla, 2001, Minireview: the OPG/RANKL/RANK system, Endocrinology, 142, 5050, 10.1210/endo.142.12.8536 Mundy, 2007, Osteoporosis and inflammation, Nutr Rev, 65, S147, 10.1301/nr.2007.dec.S147-S151 Wright, 2008, Proton pump-inhibiting drugs, calcium homeostasis, and bone health, Nutr Rev, 66, 103, 10.1111/j.1753-4887.2008.00015.x Carnielli, 1996, Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance, J Pediatr Gastroenterol Nutr, 23, 553, 10.1097/00005176-199612000-00007 Koo, 2003, Reduced bone mineralization in infants fed palm olein-containing formula: a randomized, double-blinded, prospective trial, Pediatrics, 111, 1017, 10.1542/peds.111.5.1017 Merrill, 1986, Effects of exogenous fatty acids on calcium uptake by brush-border membrane vesicles from rabbit small intestine, Biochim Biophys Acta, 855, 337, 10.1016/0005-2736(86)90079-9 Cartwright-Shamoon, 1995, A complex biochemical modulation of intestinal ion transport in rats fed on high-fat diets, J Pediatr Gastroenterol Nutr, 20, 36, 10.1097/00005176-199501000-00007 Haag, 2003, Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption, Prostaglandins Leukot Essent Fatty Acids, 68, 423, 10.1016/S0952-3278(03)00067-X Gilman, 2007, The effect of marine oil-derived n-3 fatty acids on transepithelial calcium transport in Caco-2 cell models of healthy and inflamed intestines, Br J Nutr, 97, 281, 10.1017/S0007114507201758 Maccarinelli, 2005, Ghrelin regulates proliferation and differentiation of osteoblastic cells, J Endocrinol, 184, 249, 10.1677/joe.1.05837 Delhanty, 2006, Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a, J Endocrinol, 188, 37, 10.1677/joe.1.06404 Fukushima, 2005, Ghrelin directly regulates bone formation, J Bone Miner Res, 20, 790, 10.1359/JBMR.041237 Deng, 2008, Stimulation of intramembranous bone repair in rats by ghrelin, Exp Physiol, 93, 872, 10.1113/expphysiol.2007.041962 Yasuda, 2003, Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats, Neurosci Lett, 349, 75, 10.1016/S0304-3940(03)00789-4 Sun, 2003, Deletion of ghrelin impairs neither growth nor appetite, Mol Cell Biol, 23, 7973, 10.1128/MCB.23.22.7973-7981.2003 Huda, 2007, Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects, Bone, 41, 406, 10.1016/j.bone.2007.05.006 Nass, 2008, Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial, Ann Intern Med, 149, 601, 10.7326/0003-4819-149-9-200811040-00003 Tschop, 2001, Circulating ghrelin levels are decreased in human obesity, Diabetes, 50, 707, 10.2337/diabetes.50.4.707 Robertson, 2004, Plasma ghrelin response following a period of acute overfeeding in normal weight men, Int J Obes Relat Metab Disord, 28, 727, 10.1038/sj.ijo.0802637 Ebal, 2007, Effect of a lipid-enriched diet on body composition and some regulatory hormones of food intake in growing rats, Ann Endocrinol, 68, 366, 10.1016/j.ando.2007.06.026 Handjieva-Darlenska, 2009, The effect of high-fat diet on plasma ghrelin and leptin levels in rats, J Physiol Biochem, 65, 157, 10.1007/BF03179066 Moesgaard, 2004, Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach, Regul Pept, 120, 261, 10.1016/j.regpep.2004.03.018 Delhanty, 2010, Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice, PLoS ONE, 5, e11749, 10.1371/journal.pone.0011749 Burghardt, 2010, Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls, Nutr Metab, 7, 53, 10.1186/1743-7075-7-53 Bollag, 2000, Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors, Endocrinology, 141, 1228, 10.1210/endo.141.3.7366 Zhong, 2007, Effects of glucose-dependent insulinotropic peptide on osteoclast function, Am J Physiol, 292, E543 Bollag, 2001, Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects, Mol Cell Endocrinol, 177, 35, 10.1016/S0303-7207(01)00405-1 Xie, 2007, Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass, Bone, 40, 1352, 10.1016/j.bone.2007.01.007 Ding, 2008, Impact of glucose-dependent insulinotropic peptide on age-induced bone loss, J Bone Miner Res, 23, 536, 10.1359/jbmr.071202 Miyawaki, 1999, Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice, Proc Natl Acad Sci USA, 96, 14843, 10.1073/pnas.96.26.14843 Tsukiyama, 2006, Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Molecular endocrinology, Mol Endocrinol (Baltimore, Md), 20, 1644, 10.1210/me.2005-0187 Yamada, 2008, The murine glucagon-like peptide-1 receptor is essential for control of bone resorption, Endocrinology, 149, 574, 10.1210/en.2007-1292 Sanz, 2010, Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow, Am J Physiol, 298, E634 Nuche-Berenguer, 2009, Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states, Calcif Tissue Int, 84, 453, 10.1007/s00223-009-9220-3 Krarup, 1985, Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat, Am J Physiol, 249, E195 Ellrichmann, 2008, Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7–36)-amide-1, cholecystokinin, and peptide YY concentrations, J Clin Endocrinol Metab, 93, 3995, 10.1210/jc.2008-0924 Enc, 2009, Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects, Am J Physiol Gastrointest Liver Physiol, 296, G482, 10.1152/ajpgi.90209.2008 Rocca, 2001, Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1, Endocrinology, 142, 1148, 10.1210/endo.142.3.8034 Thomsen, 1999, Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects, Am J Clin Nutr, 69, 1135, 10.1093/ajcn/69.6.1135 Gniuli, 2008, High saturated-fat diet induces apoptosis in rat enterocytes and blunts GIP and insulin-secretive response to oral glucose load, Int J Obes (Lond), 32, 871, 10.1038/ijo.2008.9 Hirasawa, 2005, Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120, Nat Med, 11, 90, 10.1038/nm1168 Parker, 2009, Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells, Diabetologia, 52, 289, 10.1007/s00125-008-1202-x Hara, 2009, Novel selective ligands for free fatty acid receptors GPR120 and GPR40, Naunyn Schmiedebergs Arch Pharmacol, 380, 247, 10.1007/s00210-009-0425-9 Cornish, 1996, Insulin increases histomorphometric indices of bone formation In vivo, Calcif Tissue Int, 59, 492, 10.1007/BF00369216 Thomas, 1998, Insulin receptor expression in primary and cultured osteoclast-like cells, Bone, 23, 181, 10.1016/S8756-3282(98)00095-7 Pun, 1989, The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line, J Bone Miner Res, 4, 853, 10.1002/jbmr.5650040610 Fulzele, 2007, Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action, J Biol Chem, 282, 25649, 10.1074/jbc.M700651200 Bouillon, 1995, Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus, J Clin Endocrinol Metab, 80, 1194 Munoz-Torres, 1996, Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus, Calcif Tissue Int, 58, 316, 10.1007/BF02509378 Thrailkill, 2005, Bone formation is impaired in a model of type 1 diabetes, Diabetes, 54, 2875, 10.2337/diabetes.54.10.2875 Ogata, 2000, Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover, J Clin Invest, 105, 935, 10.1172/JCI9017 Akune, 2002, Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts, J Cell Biol, 159, 147, 10.1083/jcb.200204046 Irwin, 2006, Normal bone density obtained in the absence of insulin receptor expression in bone, Endocrinology, 147, 5760, 10.1210/en.2006-0700 Brownlee, 1984, Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann Int Med, 101, 527, 10.7326/0003-4819-101-4-527 Giaccari, 2009, Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment, Nutr Metab Cardiovasc Dis, 19, 365, 10.1016/j.numecd.2009.03.018 Williams, 1997, Regulation of osteoclastic bone resorption by glucose, Biochem Biophys Res Commun, 235, 646, 10.1006/bbrc.1997.6795 McCabe, 2007, Understanding the pathology and mechanisms of type I diabetic bone loss, J Cell Biochem, 102, 1343, 10.1002/jcb.21573 Prentki, 2002, Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes, Diabetes, 51, S405, 10.2337/diabetes.51.2007.S405 Nolan, 2006, Fatty acid signaling in the beta-cell and insulin secretion, Diabetes, 55, S16, 10.2337/db06-S003 Samuel, 2010, Lipid-induced insulin resistance: unravelling the mechanism, Lancet, 375, 2267, 10.1016/S0140-6736(10)60408-4 Poitout, 2006, Regulation of the insulin gene by glucose and fatty acids, J Nutr, 136, 873, 10.1093/jn/136.4.873 Elks, 1993, Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release, Endocrinology, 133, 208, 10.1210/endo.133.1.8319569 Zhou, 1994, Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle, J Clin Invest, 93, 870, 10.1172/JCI117042 Kawai, 2001, Chronic effects of different fatty acids and leptin in INS-1 cells, Diabetes Res Clin Pract, 51, 1, 10.1016/S0168-8227(00)00201-1 Maedler, 2001, Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function, Diabetes, 50, 69, 10.2337/diabetes.50.1.69 Poitout, 2008, Glucolipotoxicity: fuel excess and beta-cell dysfunction, Endocr Rev, 29, 351, 10.1210/er.2007-0023 Stein, 1996, Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat, J Clin Invest, 97, 2728, 10.1172/JCI118727 Roduit, 2004, A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli, Diabetes, 53, 1007, 10.2337/diabetes.53.4.1007 Stein, 1997, The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation, J Clin Invest, 100, 398, 10.1172/JCI119546 Metz, 1988, Exogenous arachidonic acid promotes insulin release from intact or permeabilized rat islets by dual mechanisms. Putative activation of Ca2+ mobilization and protein kinase C, Diabetes, 37, 1453, 10.2337/diab.37.11.1453 Itoh, 2003, Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40, Nature, 422, 173, 10.1038/nature01478 Fujiwara, 2005, Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release, Am J Physiol, 289, E670 Nagasumi, 2009, Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice, Diabetes, 58, 1067, 10.2337/db08-1233 Nolan, 2006, Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling, Diabetologia, 49, 2120, 10.1007/s00125-006-0305-5 Steneberg, 2005, The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse, Cell Metab, 1, 245, 10.1016/j.cmet.2005.03.007 Latour, 2007, GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo, Diabetes, 56, 1087, 10.2337/db06-1532 Briaud, 2002, Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus normoglycemic rats, Diabetes, 51, 662, 10.2337/diabetes.51.3.662 Lameloise, 2001, Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?, Diabetes, 50, 803, 10.2337/diabetes.50.4.803 Chan, 2001, Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action, Diabetes, 50, 1302, 10.2337/diabetes.50.6.1302 Joseph, 2002, Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet, Diabetes, 51, 3211, 10.2337/diabetes.51.11.3211 Olofsson, 2007, Long-term exposure to glucose and lipids inhibits glucose-induced insulin secretion downstream of granule fusion with plasma membrane, Diabetes, 56, 1888, 10.2337/db06-1150 Moore, 2004, Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion, Diabetes, 53, 2610, 10.2337/diabetes.53.10.2610 Kelpe, 2003, Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis, J Biol Chem, 278, 30015, 10.1074/jbc.M302548200 Mathias, 1998, Signal transduction of stress via ceramide, Biochem J, 335, 465, 10.1042/bj3350465 Solinas, 2006, Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates, Proc Natl Acad Sci USA, 103, 16454, 10.1073/pnas.0607626103 Ruderman, 2003, Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes, Biochem Soc Trans, 31, 202, 10.1042/bst0310202 El-Assaad, 2003, Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death, Endocrinology, 144, 4154, 10.1210/en.2003-0410 Lupi, 2002, Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated, Diabetes, 51, 1437, 10.2337/diabetes.51.5.1437 Shimabukuro, 1998, Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression, J Biol Chem, 273, 32487, 10.1074/jbc.273.49.32487 Piro, 2002, Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress, Metabolism, 51, 1340, 10.1053/meta.2002.35200 Maestre, 2003, Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1, Endocrinology, 144, 335, 10.1210/en.2001-211282 Busch, 2002, Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function, Diabetes, 51, 977, 10.2337/diabetes.51.4.977 Laybutt, 2007, Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes, Diabetologia, 50, 752, 10.1007/s00125-006-0590-z Azevedo-Martins, 2006, Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells, Toxicol In Vitro, 20, 1106, 10.1016/j.tiv.2006.02.007 Eitel, 2002, Different role of saturated and unsaturated fatty acids in beta-cell apoptosis, Biochem Biophys Res Commun, 299, 853, 10.1016/S0006-291X(02)02752-3 Welters, 2004, Mono-unsaturated fatty acids protect against beta-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure, FEBS Lett, 560, 103, 10.1016/S0014-5793(04)00079-1 Wei, 2010, Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death, Diabetes, 59, 471, 10.2337/db09-0284 Furstova, 2008, Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y, Life Sci, 82, 684, 10.1016/j.lfs.2007.12.023 Maedler, 2003, Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function, Diabetes, 52, 726, 10.2337/diabetes.52.3.726 Cnop, 2008, Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes, Biochem Soc Trans, 36, 348, 10.1042/BST0360348 Dhayal, 2008, Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11, Br J Pharmacol, 153, 1718, 10.1038/bjp.2008.43 Papadimitriou, 2007, Anti-apoptotic effects of arachidonic acid and prostaglandin E2 in pancreatic beta-cells, Cell Physiol Biochem, 20, 607, 10.1159/000107544 Beeharry, 2003, Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid, Mutat Res, 530, 27, 10.1016/S0027-5107(03)00134-9 Bellenger, 2011, High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition, Diabetes, 60, 1090, 10.2337/db10-0901 Alam, 1993, Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts, Exp Physiol, 78, 183, 10.1113/expphysiol.1993.sp003679 Naot, 2008, The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism, Bone, 43, 813, 10.1016/j.bone.2008.07.003 Cornish, 1998, Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice, Am J Physiol, 275, E694 Cornish, 1999, Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts, J Bone Miner Res, 14, 1302, 10.1359/jbmr.1999.14.8.1302 Dacquin, 2004, Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo, J Cell Biol, 164, 509, 10.1083/jcb.200312135 Cornish, 1995, Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice, Biochem Biophys Res Commun, 207, 133, 10.1006/bbrc.1995.1163 Horcajada-Molteni, 2001, Amylin and bone metabolism in streptozotocin-induced diabetic rats, J Bone Miner Res, 16, 958, 10.1359/jbmr.2001.16.5.958 Horcajada-Molteni, 2000, Amylin inhibits ovariectomy-induced bone loss in rats, J Endocrinol, 165, 663, 10.1677/joe.0.1650663 Bronsky, 2004, Amylin fasting plasma levels are decreased in patients with osteoporosis, Osteoporos Int, 15, 243, 10.1007/s00198-003-1538-5 Reda, 2002, Amylin, food intake, and obesity, Obes Res, 10, 1087, 10.1038/oby.2002.147 Pieber, 1994, Direct plasma radioimmunoassay for rat amylin-(1–37): concentrations with acquired and genetic obesity, Am J Physiol, 267, E156 Westermark, 1998, Increased release of IAPP in response to long-term high fat intake in mice, Horm Metab Res, 30, 256, 10.1055/s-2007-978878 Qi, 2010, Fatty acids induce amylin expression and secretion by pancreatic beta-cells, Am J Physiol, 298, E99 Guardado-Mendoza, 2009, Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons, Proc Natl Acad Sci USA, 106, 13992, 10.1073/pnas.0906471106 Westermark, 1995, Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide, Mol Med (Cambridge, Mass), 1, 542, 10.1007/BF03401591 Ma, 2002, Effects of free fatty acid on polymerization of islet amyloid polypeptide (IAPP) in vitro and on amyloid fibril formation in cultivated isolated islets of transgenic mice overexpressing human IAPP, Mol Med (Cambridge, Mass), 8, 863, 10.1007/BF03402092 Cornish, 2007, Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo, Am J Physiol, 292, E117 Unger, 2001, Diseases of liporegulation: new perspective on obesity and related disorders, FASEB J, 15, 312, 10.1096/fj.00-0590 McGavock, 2006, Adiposity of the heart, revisited, Ann Intern Med, 144, 517, 10.7326/0003-4819-144-7-200604040-00011 Guanabens, 2010, Liver and bone, Arch Biochem Biophys, 503, 84, 10.1016/j.abb.2010.05.030 Zou, 2006, High-fat emulsion-induced rat model of nonalcoholic steatohepatitis, Life Sci, 79, 1100, 10.1016/j.lfs.2006.03.021 Carmiel-Haggai, 2005, A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats, FASEB J, 19, 136, 10.1096/fj.04-2291fje Vilar, 2008, High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects, Nutrition (Burbank, Los Angeles County, Calif), 24, 1097, 10.1016/j.nut.2008.05.017 Wobser, 2009, Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells, Cell Res, 19, 996, 10.1038/cr.2009.73 Feldstein, 2004, Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway, Hepatology (Baltimore, Md), 40, 185, 10.1002/hep.20283 Kawelke, 2008, Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation, J Bone Miner Res, 23, 1278, 10.1359/jbmr.080313 Cemborain, 1998, Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment, J Hepatol, 28, 122, 10.1016/S0168-8278(98)80211-0 Gallego-Rojo, 1998, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis, Hepatology (Baltimore, Md), 28, 695, 10.1002/hep.510280315 Giouleme, 2006, Pathogenesis of osteoporosis in liver cirrhosis, Hepatogastroenterology, 53, 938 Tetri, 2008, Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent, Am J Physiol Gastrointest Liver Physiol, 295, G987, 10.1152/ajpgi.90272.2008 Obara, 2010, Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice, J Hepatol, 53, 326, 10.1016/j.jhep.2010.02.029 Kim, 2008, Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice, Mol Nutr Food Res, 52, 965, 10.1002/mnfr.200700315 Sekiya, 2003, Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression, Hepatology (Baltimore, Md), 38, 1529, 10.1053/jhep.2003.09028 Kajikawa, 2009, Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progression of d-galactosamine-induced hepatitis in mice fed with a high-fat/high-sucrose diet, Biochim Biophys Acta, 1791, 281, 10.1016/j.bbalip.2009.01.014 Hao, 2010, Omega-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes, J Pediatr Surg, 45, 2412, 10.1016/j.jpedsurg.2010.08.044 Capanni, 2006, Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study, Aliment Pharmacol Ther, 23, 1143, 10.1111/j.1365-2036.2006.02885.x Zhu, 2008, Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia, World J Gastroenterol, 14, 6395, 10.3748/wjg.14.6395 Sofi, 2010, Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study, Int J Food Sci Nutr, 61, 792, 10.3109/09637486.2010.487480 Tanaka, 2008, Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis, J Clin Gastroenterol, 42, 413, 10.1097/MCG.0b013e31815591aa Nobili, 2010, Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial, Arch Dis Child, 96, 350, 10.1136/adc.2010.192401 Hussein, 2007, Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats, World J Gastroenterol, 13, 361, 10.3748/wjg.v13.i3.361 Nagao, 2005, Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats, J Nutr, 135, 9, 10.1093/jn/135.1.9 Lieber, 2000, Alcoholic liver disease: new insights in pathogenesis lead to new treatments, J Hepatol, 32, 113, 10.1016/S0168-8278(00)80420-1 Tilg, 2000, Cytokines in alcoholic and nonalcoholic steatohepatitis, N Engl J Med, 343, 1467, 10.1056/NEJM200011163432007 Ronis, 2004, Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition, J Nutr, 134, 904, 10.1093/jn/134.4.904 Nanji, 1989, Beef fat prevents alcoholic liver disease in the rat, Alcohol Clin Exp Res, 13, 15, 10.1111/j.1530-0277.1989.tb00276.x Nanji, 1997, Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat, Hepatology (Baltimore, Md), 26, 1538, 10.1002/hep.510260622 Nanji, 2001, Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines, Am J Physiol Gastrointest Liver Physiol, 281, G1348, 10.1152/ajpgi.2001.281.6.G1348 Kume, 2007, Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet, J Am Soc Nephrol, 18, 2715, 10.1681/ASN.2007010089 Tanaka, 2011, Fenofibrate, a PPARalpha agonist, has renoprotective effects in mice by enhancing renal lipolysis, Kidney Int, 79, 871, 10.1038/ki.2010.530 Okamura, 2009, CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD, J Am Soc Nephrol, 20, 495, 10.1681/ASN.2008010009 Li, 2010, Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet, J Thromb Haemost, 8, 2122, 10.1111/j.1538-7836.2010.03976.x Soumura, 2010, Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell, Biochem Biophys Res Commun, 402, 265, 10.1016/j.bbrc.2010.10.012 Barcelli, 1990, High linoleic acid diets ameliorate diabetic nephropathy in rats, Am J Kidney Dis, 16, 244, 10.1016/S0272-6386(12)81024-9 Chin, 2010, Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals, Nephrol Dial Transpl, 25, 1450, 10.1093/ndt/gfp695 Drury, 2009, Dietary trans-10, cis-12 conjugated linoleic acid reduces early glomerular enlargement and elevated renal cyclooxygenase-2 levels in young obese fa/fa zucker rats, J Nutr, 139, 285, 10.3945/jn.108.101345 Cappelli, 1997, N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease, J Nephrol, 10, 157 Lu, 2003, Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats, J Nutr, 133, 180, 10.1093/jn/133.1.180 Ogborn, 2003, Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease, Kidney Int, 64, 1214, 10.1046/j.1523-1755.2003.00215.x Friedman, 2010, Omega-3 fatty acid supplementation in advanced kidney disease, Semin Dial, 23, 396, 10.1111/j.1525-139X.2010.00748.x Crepaldi, 2007, Osteoporosis and body composition, J Endocrinol Invest, 30, 42 Visser, 1998, High body fatness, but not low fat-free mass, predicts disability in older men and women: the cardiovascular health study, Am J Clin Nutr, 68, 584, 10.1093/ajcn/68.3.584 Payette, 1998, Muscle strength and functional mobility in relation to lean body mass in free-living frail elderly women, Eur J Clin Nutr, 52, 45, 10.1038/sj.ejcn.1600513 Silveira, 2008, Updating the effects of fatty acids on skeletal muscle, J Cell Physiol, 217, 1, 10.1002/jcp.21514 Kraegen, 2008, Free fatty acids and skeletal muscle insulin resistance, Curr Opin Lipidol, 19, 235, 10.1097/01.mol.0000319118.44995.9a Kimball, 1998, Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts, Am J Physiol, 274, C221, 10.1152/ajpcell.1998.274.1.C221 Balage, 2001, Amino acids and insulin are both required to regulate assembly of the eIF4E. eIF4G complex in rat skeletal muscle, Am J Physiol, 281, E565 Prod’homme, 2005, Differential effects of insulin and dietary amino acids on muscle protein synthesis in adult and old rats, J Physiol, 563, 235, 10.1113/jphysiol.2004.068841 Anderson, 2008, Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice, Metabolism, 57, 347, 10.1016/j.metabol.2007.10.009 Belfort, 2005, Dose-response effect of elevated plasma free fatty acid on insulin signaling, Diabetes, 54, 1640, 10.2337/diabetes.54.6.1640 Pedrini, 2005, Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels, Diabetologia, 48, 756, 10.1007/s00125-005-1684-8 Sitnick, 2009, Chronic high fat feeding attenuates load-induced hypertrophy in mice, J Physiol, 587, 5753, 10.1113/jphysiol.2009.180174 Pfeilschifter, 2002, Changes in proinflammatory cytokine activity after menopause, Endocr Rev, 23, 90, 10.1210/edrv.23.1.0456 Rachon, 2002, Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women, J Endocrinol, 172, 387, 10.1677/joe.0.1720387 Ralston, 1990, Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women, J Bone Miner Res., 5, 983, 10.1002/jbmr.5650050912 Pacifici, 1991, Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells, Proc Natl Acad Sci USA, 88, 5134, 10.1073/pnas.88.12.5134 Lorenzo, 1998, Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy, Endocrinology, 139, 3022, 10.1210/endo.139.6.6128 Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, Embo J, 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x Vargas, 1996, Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor, J Bone Miner Res, 11, 1736, 10.1002/jbmr.5650111117 Ammann, 1997, Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency, J Clin Invest, 99, 1699, 10.1172/JCI119333 Kimble, 1995, Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period, Endocrinology, 136, 3054, 10.1210/endo.136.7.7789332 Aoki, 2005, Overexpression of the human interleukin 1a gene causes osteopenia in mice, J Rheumatol, 32, 320 Schett, 2003, Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice, Arthritis Rheum, 48, 2042, 10.1002/art.11150 Krabbe, 2004, Inflammatory mediators in the elderly, Exp Gerontol, 39, 687, 10.1016/j.exger.2004.01.009 Bruunsgaard, 2001, Aging and proinflammatory cytokines, Curr Opin Hematol, 8, 131, 10.1097/00062752-200105000-00001 Kitaura, 2005, M-CSF mediates TNF-induced inflammatory osteolysis, J Clin Invest, 115, 3418, 10.1172/JCI26132 Hofbauer, 1999, Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells, Bone, 25, 255, 10.1016/S8756-3282(99)00162-3 Kwan Tat, 2004, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology, Cytokine Growth Factor Rev, 15, 49, 10.1016/j.cytogfr.2003.10.005 Gilbert, 2002, Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha, J Biol Chem, 277, 2695, 10.1074/jbc.M106339200 Ding, 2009, TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells, Life Sci, 84, 499, 10.1016/j.lfs.2009.01.013 Lacey, 2009, Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation, Osteoarthritis Cartilage, 17, 735, 10.1016/j.joca.2008.11.011 Kaneki, 2006, Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts, J Biol Chem, 281, 4326, 10.1074/jbc.M509430200 Lu, 2006, Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways, J Biol Chem, 281, 6297, 10.1074/jbc.M507804200 Li, 2007, Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB, J Bone Miner Res, 22, 646, 10.1359/jbmr.070121 Guilherme, 2008, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes, Nat Rev, 9, 367, 10.1038/nrm2391 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 Lundman, 2007, A high-fat meal is accompanied by increased plasma interleukin-6 concentrations, Nutr Metab Cardiovasc Dis, 17, 195, 10.1016/j.numecd.2005.11.009 Riserus, 2008, Fatty acids and insulin sensitivity, Curr Opin Clin Nutr Metab Care, 11, 100, 10.1097/MCO.0b013e3282f52708 Kalupahana, 2010, Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation, J Nutr, 140, 1915, 10.3945/jn.110.125732 Schaeffler, 2009, Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity, Immunology, 126, 233, 10.1111/j.1365-2567.2008.02892.x Takahashi, 2008, JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro, Am J Physiol, 294, E898 Weisberg, 2006, CCR2 modulates inflammatory and metabolic effects of high-fat feeding, J Clin Invest, 116, 115, 10.1172/JCI24335 Suganami, 2007, Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages, Arterioscler Thromb Vasc Biol, 27, 84, 10.1161/01.ATV.0000251608.09329.9a van Dijk, 2009, A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome, Am J Clin Nutr, 90, 1656, 10.3945/ajcn.2009.27792 Kennedy, 2009, Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications, J Nutr, 139, 1, 10.3945/jn.108.098269 Zhao, 2007, Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects, Am J Clin Nutr, 85, 385, 10.1093/ajcn/85.2.385 Uchida, 2010, Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice, J Bone Miner Metab, 29, 404, 10.1007/s00774-010-0234-8 Kang, 2004, Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids, Nature, 427, 504, 10.1038/427504a Bordin, 2003, Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells, Biochemistry, 42, 4485, 10.1021/bi026842n Rahman, 2009, The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet, Oxid Med Cell Longev, 2, 307, 10.4161/oxim.2.5.9579 Halade, 2011, Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice, Exp Gerontol, 46, 43, 10.1016/j.exger.2010.09.014 Bhattacharya, 2007, Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice, J Nutr Biochem, 18, 23, 10.1016/j.jnutbio.2006.02.005 Halade, 2010, High fat diet-induced animal model of age-associated obesity and osteoporosis, J Nutr Biochem, 21, 1162, 10.1016/j.jnutbio.2009.10.002 Priante, 2002, Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid, Clin Sci (Lond), 102, 403, 10.1042/cs1020403 Coetzee, 2007, Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells, J Nutr Biochem, 18, 54, 10.1016/j.jnutbio.2006.03.002 Rahman, 2008, Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid, J Cell Physiol, 214, 201, 10.1002/jcp.21188 Platt, 2009, Effects of 9cis, 11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes, Lipids Health Dis, 8, 15, 10.1186/1476-511X-8-15 Walsh, 2006, Osteoimmunology: interplay between the immune system and bone metabolism, Annu Rev Immunol, 24, 33, 10.1146/annurev.immunol.24.021605.090646 Leibbrandt, 2008, RANK/RANKL: regulators of immune responses and bone physiology, Ann N Y Acad Sci, 1143, 123, 10.1196/annals.1443.016 Graham, 2009, Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss, Clin Immunol, 133, 265, 10.1016/j.clim.2009.07.011 Droge, 2002, Free radicals in the physiological control of cell function, Physiol Rev, 82, 47, 10.1152/physrev.00018.2001 Reth, 2002, Hydrogen peroxide as second messenger in lymphocyte activation, Nat Immunol, 3, 1129, 10.1038/ni1202-1129 Basu, 2001, Association between oxidative stress and bone mineral density, Biochem Biophys Res Commun, 288, 275, 10.1006/bbrc.2001.5747 Valko, 2007, Free radicals and antioxidants in normal physiological functions and human disease, Int J Biochem Cell Biol, 39, 44, 10.1016/j.biocel.2006.07.001 Sendur, 2009, Antioxidant status in patients with osteoporosis: a controlled study, Joint Bone Spine, 76, 514, 10.1016/j.jbspin.2009.02.005 He, 2010, Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production, Biochem Biophys Res Commun, 401, 356, 10.1016/j.bbrc.2010.09.053 Manolagas, 2010, From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis, Endocr Rev, 31, 266, 10.1210/er.2009-0024 Janssen-Heininger, 2008, Redox-based regulation of signal transduction: principles, pitfalls, and promises, Free Radic Biol Med, 45, 1, 10.1016/j.freeradbiomed.2008.03.011 Bai, 2005, Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast, J Biol Chem, 280, 17497, 10.1074/jbc.M409332200 Riley, 1994, Free radicals in biology: oxidative stress and the effects of ionizing radiation, Int J Radiat Biol, 65, 27, 10.1080/09553009414550041 Beckman, 1998, The free radical theory of aging matures, Physiol Rev, 78, 547, 10.1152/physrev.1998.78.2.547 Halliwell, 1984, Free radicals, lipid peroxidation, and cell damage, Lancet, 2, 1095, 10.1016/S0140-6736(84)91530-7 Morrow, 1996, The isoprostanes. Current knowledge and directions for future research, Biochem Pharmacol, 51, 1, 10.1016/0006-2952(95)02072-1 Negre-Salvayre, 2010, Pathological aspects of lipid peroxidation, Free Radic Res, 44, 1125, 10.3109/10715762.2010.498478 Muthusami, 2005, Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats, Clin Chim Acta, 360, 81, 10.1016/j.cccn.2005.04.014 Xiao, 2010, Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice, Nutrition (Burbank, Los Angeles County, Calif), 26, 1188, 10.1016/j.nut.2009.11.021 Parhami, 2001, Atherogenic high-fat diet reduces bone mineralization in mice, J Bone Miner Res, 16, 182, 10.1359/jbmr.2001.16.1.182 Schulz, 2004, Aortic calcification and the risk of osteoporosis and fractures, J Clin Endocrinol Metab, 89, 4246, 10.1210/jc.2003-030964 Marcovitz, 2005, Usefulness of bone mineral density to predict significant coronary artery disease, Am J Cardiol, 96, 1059, 10.1016/j.amjcard.2005.06.034 Farhat, 2006, Volumetric BMD and vascular calcification in middle-aged women: the study of women’s health across the nation, J Bone Miner Res, 21, 1839, 10.1359/jbmr.060903 Brooks, 2011, The fatty acid oxidation product 15-A(3t)-isoprostane is a potent inhibitor of NFkappaB transcription and macrophage transformation, J Neurochem, 119, 604, 10.1111/j.1471-4159.2011.07422.x Musiek, 2005, Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages, J Biol Chem, 280, 35562, 10.1074/jbc.M504785200 Sardesai, 1992, The essential fatty acids, Nutr Clin Pract, 7, 179, 10.1177/0115426592007004179 Calder, 2009, Omega-3 polyunsaturated fatty acids and human health outcomes, Biofactors, 35, 266, 10.1002/biof.42 Ricciotti, 2011, Prostaglandins and inflammation, Arterioscler Thromb Vasc Biol, 31, 986, 10.1161/ATVBAHA.110.207449 Basu, 2010, Bioactive eicosanoids: role of prostaglandin F(2alpha) and F-isoprostanes in inflammation and oxidative stress related pathology, Mol Cells, 30, 383, 10.1007/s10059-010-0157-1 Galli, 2009, Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review, Ann Nutr Metab, 55, 123, 10.1159/000228999 Hikiji, 2008, The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease, Prog Lipid Res, 47, 107, 10.1016/j.plipres.2007.12.003 Levin, 2002, Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2, Biochem J, 365, 489, 10.1042/bj20011798 Rodriguez-Lagunas, 2013, Effect of eicosapentaenoic acid-derived prostaglandin E3 on intestinal epithelial barrier function, Prostaglandins Leukot Essent Fatty Acids, 88, 339, 10.1016/j.plefa.2013.02.001 Poulsen, 2008, Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake, Am J Hematol, 83, 437, 10.1002/ajh.21170 Hasturk, 2006, RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis, FASEB J, 20, 401, 10.1096/fj.05-4724fje Hasturk, 2007, Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo, J Immunol, 179, 7021, 10.4049/jimmunol.179.10.7021 Herrera, 2008, An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption, Br J Pharmacol, 155, 1214, 10.1038/bjp.2008.367 Ji, 2011, Emerging roles of resolvins in the resolution of inflammation and pain, Trends Neurosci, 34, 599, 10.1016/j.tins.2011.08.005 Seki, 2009, Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1, Prostaglandins Other Lipid Mediat, 89, 126, 10.1016/j.prostaglandins.2009.03.002 Zhu, 2013, Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1, FASEB J, 27, 3344, 10.1096/fj.12-220228 McCauley, 2014, Cutting edge: parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2, J Immunol, 193, 26, 10.4049/jimmunol.1301945 Galli, 2011, FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena?, J Periodontal Res, 46, 397, 10.1111/j.1600-0765.2011.01354.x Almeida, 2009, Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton, J Biol Chem, 284, 27438, 10.1074/jbc.M109.023572 Klein, 2004, Regulation of bone mass in mice by the lipoxygenase gene Alox15, Science (New York, NY), 303, 229, 10.1126/science.1090985 Priante, 2005, Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells, Clin Sci (Lond), 109, 177, 10.1042/CS20040369 Rahman, 2011, Docosahexaenoic acid inhibits UVB-induced activation of NF-kappaB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling, PloS ONE, 6, e28065, 10.1371/journal.pone.0028065 Goettsch, 2013, NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis, J Clin Invest, 123, 4731, 10.1172/JCI67603 Harrison, 2013, Bone disorders: targeting NOX4 knocks down osteoporosis, Nat Rev Drug Discov, 12, 904, 10.1038/nrd4182 Wittrant, 2009, Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-{kappa}B ligand (RANKL) expression by osteoblasts, Endocrinology, 150, 4977, 10.1210/en.2009-0248 van’t Hof, 2001, Nitric oxide and bone, Immunology, 103, 255, 10.1046/j.1365-2567.2001.01261.x Kim, 2006, Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha, Free Radic Biol Med, 40, 1483, 10.1016/j.freeradbiomed.2005.10.066 Koh, 2005, Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells, J Endocrinol, 185, 401, 10.1677/joe.1.05995 Xiao, 2010, Expression of genes associated with bone resorption is increased and bone formation is decreased in mice fed a high-fat diet, Lipids, 45, 345, 10.1007/s11745-010-3397-0 Saha, 2011, Antioxidant effect of vegetable oils containing conjugated linolenic acid isomers against induced tissue lipid peroxidation and inflammation in rat model, Chem Biol Interact, 190, 109, 10.1016/j.cbi.2011.02.030 Yu, 2002, Conjugated linoleic acid isomers differ in their free radical scavenging properties, J Agric Food Chem, 50, 4135, 10.1021/jf020086a Spilmont, 2013, Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status, J Nutr Biochem, 24, 1840, 10.1016/j.jnutbio.2013.04.005 Berger, 1996, Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice, Endocrinology, 137, 4189, 10.1210/endo.137.10.8828476 Jeon, 2003, Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts, J Biol Chem, 278, 23270, 10.1074/jbc.M211610200 Chan, 2007, PPAR agonists modulate human osteoclast formation and activity in vitro, Bone, 40, 149, 10.1016/j.bone.2006.07.029 Hounoki, 2008, Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression, Bone, 42, 765, 10.1016/j.bone.2007.11.016 Mano, 2000, Cloning and function of rabbit peroxisome proliferator-activated receptor delta/beta in mature osteoclasts, J Biol Chem, 275, 8126, 10.1074/jbc.275.11.8126 Viccica, 2010, The role of PPARgamma for the osteoblastic differentiation, J Endocrinol Invest, 33, 9 Wan, 2007, PPAR-gamma regulates osteoclastogenesis in mice, Nat Med, 13, 1496, 10.1038/nm1672 Still, 2008, The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo, Calcif Tissue Int, 83, 285, 10.1007/s00223-008-9175-9 Cortez, 2013, A high-fat diet increases IL-1, IL-6, and TNF-alpha production by increasing NF-kappaB and attenuating PPAR-gamma expression in bone marrow mesenchymal stem cells, Inflammation, 36, 379, 10.1007/s10753-012-9557-z Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J Clin Invest, 116, 3015, 10.1172/JCI28898 Coenen, 2009, Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice, Diabetologia, 52, 318, 10.1007/s00125-008-1221-7 Johnson, 2004, A genetic basis for the “Adonis” phenotype of low adiposity and strong bones, FASEB J, 18, 1282, 10.1096/fj.04-1572fje Oh, 2010, Saturated fatty acids enhance osteoclast survival, J Lipid Res, 51, 892, 10.1194/jlr.M800626 Nguyen, 2007, A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways, J Biol Chem, 282, 35279, 10.1074/jbc.M706762200 Huang, 2012, Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways, J Lipid Res, 53, 2002, 10.1194/jlr.D029546 Snodgrass, 2013, Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids, J Immunol, 191, 4337, 10.4049/jimmunol.1300298 Lee, 2004, Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1, J Biol Chem, 279, 16971, 10.1074/jbc.M312990200 Norris, 2012, Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling, Proc Natl Acad Sci USA, 109, 8517, 10.1073/pnas.1200189109 Cornish, 2008, Modulation of osteoclastogenesis by fatty acids, Endocrinology, 149, 5688, 10.1210/en.2008-0111 Schmidt, 2011, Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40, J Biol Chem, 286, 11890, 10.1074/jbc.C110.200477 Katsuma, 2005, Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1, J Biol Chem, 280, 19507, 10.1074/jbc.M412385200 Covington, 2006, The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing, Biochem Soc Trans, 34, 770, 10.1042/BST0340770 Graciano, 2011, NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets, J Cell Physiol, 226, 1110, 10.1002/jcp.22432 Mancini AD, 2015, GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit, Diabetes Obes Metab, 10.1111/dom.12442 Cartoni, 2010, Taste preference for fatty acids is mediated by GPR40 and GPR120, J Neurosci, 30, 8376, 10.1523/JNEUROSCI.0496-10.2010 Matsumura, 2007, GPR expression in the rat taste bud relating to fatty acid sensing, Biomed Res (Tokyo, Japan), 28, 49, 10.2220/biomedres.28.49 Tang, 2011, G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer, Int J Cancer, 128, 847, 10.1002/ijc.25638 Gotoh, 2007, The regulation of adipogenesis through GPR120, Biochem Biophys Res Commun, 354, 591, 10.1016/j.bbrc.2007.01.028 Ge, 2008, Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids, Endocrinology, 149, 4519, 10.1210/en.2008-0059 Xiong, 2004, Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41, Proc Natl Acad Sci USA, 101, 1045, 10.1073/pnas.2637002100 Nilsson, 2003, Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids, Biochem Biophys Res Commun, 303, 1047, 10.1016/S0006-291X(03)00488-1 Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041 Philippe, 2013, GW9508, a free fatty acid receptor agonist, specifically induces cell death in bone resorbing precursor cells through increased oxidative stress from mitochondrial origin, Exp Cell Res, 319, 3035, 10.1016/j.yexcr.2013.08.013 Wauquier, 2013, The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation, J Biol Chem, 288, 6542, 10.1074/jbc.M112.429084 Gao, 2015, Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs, Biochimie, 110, 36, 10.1016/j.biochi.2015.01.001 Monfoulet, 2015, Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis, Exp Biol Med, 10.1177/1535370214565078 Gras, 2009, Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor, Am J Physiol, 296, L970 Mieczkowska, 2012, Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism, J Biol Chem, 287, 23517, 10.1074/jbc.M111.324814 Gao, 2013, Resolvin E1 and chemokine-like receptor 1 mediate bone preservation, J Immunol, 190, 689, 10.4049/jimmunol.1103688 Krishnamoorthy, 2010, Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc Natl Acad Sci USA, 107, 1660, 10.1073/pnas.0907342107 Recchiuti, 2013, Resolvin D1 and its GPCRs in resolution circuits of inflammation, Prostaglandins Other Lipid Mediat, 107, 64, 10.1016/j.prostaglandins.2013.02.004 Spite, 2014, Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases, Cell Metab, 19, 21, 10.1016/j.cmet.2013.10.006 Boeyens, 2014, Effects of omega3- and omega6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study, Nutrients, 6, 2584, 10.3390/nu6072584 Yamashima, 2015, Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health, Prog Lipid Res, 58, 40, 10.1016/j.plipres.2015.01.002 Lappe, 2013, Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study, Eur J Nutr, 52, 203, 10.1007/s00394-012-0304-x Park, 2013, Conjugated linoleic acid and calcium co-supplementation improves bone health in ovariectomised mice, Food Chem, 140, 280, 10.1016/j.foodchem.2012.12.067 Wittwer, 2011, Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives, Mol Nutr Food Res, 55, 341, 10.1002/mnfr.201000512 Sales, 2014, Nutrigenomics: definitions and advances of this new science, J Nutr Metabol, 2014, 202759, 10.1155/2014/202759 Devlin, 2015, The bone-fat interface: basic and clinical implications of marrow adiposity, Lancet Diabetes Endocrinol, 3, 141, 10.1016/S2213-8587(14)70007-5 Kruger, 1998, Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis, Aging, 10, 385 Dodin, 2005, The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial, J Clin Endocrinol Metab, 90, 1390, 10.1210/jc.2004-1148 Appleton, 2011, Supplementation with a low-moderate dose of n-3 long-chain PUFA has no short-term effect on bone resorption in human adults, Br J Nutr, 105, 1145, 10.1017/S0007114510004861 Tartibian, 2011, Long-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures study, Nutr Metab, 8, 71, 10.1186/1743-7075-8-71 Hutchins-Wiese, 2014, High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study, Nutr Cancer, 66, 68, 10.1080/01635581.2014.847964 Weiss, 2005, Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study, Am J Clin Nutr, 81, 934, 10.1093/ajcn/81.4.934 Genaro, 2010, Influence of body composition on bone mass in postmenopausal osteoporotic women, Arch Gerontol Geriatr, 51, 295, 10.1016/j.archger.2009.12.006 Orchard, 2012, A systematic review of omega-3 fatty acids and osteoporosis, Br J Nutr, 107, S253, 10.1017/S0007114512001638 Arikan, 2011, Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis, Biol Trace Elem Res, 144, 407, 10.1007/s12011-011-9109-7 Farina, 2012, Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study, J Bone Miner Res, 27, 1222, 10.1002/jbmr.1581 Jarvinen, 2012, Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women, Eur J Clin Nutr, 66, 496, 10.1038/ejcn.2011.188 Mangano, 2014, An investigation of the association between omega 3 FA and bone mineral density among older adults: results from the National Health and Nutrition Examination Survey years 2005–2008, Osteoporos Int, 25, 1033, 10.1007/s00198-013-2501-8